These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11606948)

  • 1. Regulation of lipid and lipoprotein metabolism by retinoids.
    Staels B
    J Am Acad Dermatol; 2001 Nov; 45(5):S158-67. PubMed ID: 11606948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of action for vitamin A-derived hormones.
    Zhang XK; Pfahl M
    Prog Clin Biol Res; 1994; 387():59-71. PubMed ID: 7972260
    [No Abstract]   [Full Text] [Related]  

  • 4. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
    van Neerven S; Kampmann E; Mey J
    Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activities of retinoic acid receptors.
    Lefebvre P; Martin PJ; Flajollet S; Dedieu S; Billaut X; Lefebvre B
    Vitam Horm; 2005; 70():199-264. PubMed ID: 15727806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of oral vitamin A derivatives on lipid metabolism - What recommendations can be derived for dealing with this issue in the daily dermatological practice?
    Klör HU; Weizel A; Augustin M; Diepgen TL; Elsner P; Homey B; Kapp A; Ruzicka T; Luger T
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):600-6. PubMed ID: 21392258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.
    Ziouzenkova O; Plutzky J
    FEBS Lett; 2008 Jan; 582(1):32-8. PubMed ID: 18068127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid X receptor-selective ligands produce malformations in Xenopus embryos.
    Minucci S; Saint-Jeannet JP; Toyama R; Scita G; DeLuca LM; Tiara M; Levin AA; Ozato K; Dawid IB
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1803-7. PubMed ID: 8700839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells.
    Szanto A; Nagy L
    Mol Pharmacol; 2005 Jun; 67(6):1935-43. PubMed ID: 15741503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoids and vitamin D analogues: action on nuclear transcription.
    Griffiths CE
    Hosp Med; 1998 Jan; 59(1):12-6. PubMed ID: 9798558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoids: potential in cancer prevention and therapy.
    Clarke N; Germain P; Altucci L; Gronemeyer H
    Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
    J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids, neoplasia and differentiation therapy.
    Lippman SM; Davies PJ
    Cancer Chemother Biol Response Modif; 1997; 17():349-62. PubMed ID: 9551220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.